Galloyl-RGD as a new cosmetic ingredient

BMC Biochem. 2014 Aug 8:15:18. doi: 10.1186/1471-2091-15-18.

Abstract

Background: The cosmetics market has rapidly increased over the last years. For example, in 2011 it reached 242.8 billion US dollars, which was a 3.9% increase compared to 2010. There have been many recent trials aimed at finding the functional ingredients for new cosmetics. Gallic acid is a phytochemical derived from various herbs, and has anti-fungal, anti-viral, and antioxidant properties. Although phytochemicals are useful as cosmetic ingredients, they have a number of drawbacks, such as thermal stability, residence time in the skin, and permeability through the dermal layer. To overcome these problems, we considered conjugation of gallic acid with a peptide.

Results: We synthesized galloyl-RGD, which represents a conjugate of gallic acid and the peptide RGD, purified it by HPLC and characterized by MALDI-TOF with the aim of using it as a new cosmetic ingredient. Thermal stability of galloyl-RGD was tested at alternating temperatures (consecutive 4°C, 20°C, or 40°C for 8 h each) on days 2, 21, 41, and 61. Galloyl-RGD was relatively safe to HaCaT keratinocytes, as their viability after 48 h incubation with 500 ppm galloyl-RGD was 93.53%. In the group treated with 50 ppm galloyl-RGD, 85.0% of free radicals were removed, whereas 1000 ppm galloyl-RGD suppressed not only L-DOPA formation (43.8%) but also L-DOPA oxidation (54.4%).

Conclusions: Galloyl-RGD is a promising candidate for a cosmetic ingredient.

MeSH terms

  • Antioxidants / chemistry
  • Antioxidants / pharmacology*
  • Biphenyl Compounds / metabolism
  • Cell Line
  • Cell Survival / drug effects
  • Cosmetics / chemistry*
  • Cosmetics / pharmacology
  • Dopamine Agents
  • Gallic Acid / chemistry
  • Gallic Acid / pharmacology*
  • Humans
  • Keratinocytes / drug effects*
  • Keratinocytes / physiology
  • Keratinocytes / radiation effects
  • Levodopa / antagonists & inhibitors*
  • Oligopeptides / chemical synthesis*
  • Oligopeptides / pharmacology*
  • Picrates / metabolism
  • Plants
  • Protein Stability
  • Reactive Oxygen Species / metabolism
  • Ultraviolet Rays / adverse effects

Substances

  • Antioxidants
  • Biphenyl Compounds
  • Cosmetics
  • Dopamine Agents
  • Oligopeptides
  • Picrates
  • Reactive Oxygen Species
  • Levodopa
  • Gallic Acid
  • arginyl-glycyl-aspartic acid
  • 1,1-diphenyl-2-picrylhydrazyl